Starting February 5, 2024, tens of thousands of children in Burkina Faso will be protected against malaria with the introduction of the RTS,S vaccine. This news is a significant relief for parents and healthcare professionals who have been battling this disease for decades in one of the world’s hardest-hit countries.
In 2021, Burkina Faso reported nearly 12.5 million malaria cases, with an incidence rate of 569 cases per 1000 inhabitants. Official reports indicate 4,355 deaths, but WHO estimates the actual number could be as high as 18,976.
The disease takes a toll, especially on children under 5 and pregnant women. The vulnerability of these groups underscores the need for effective intervention.
On February 5, 2024, Burkina Faso will introduce the RTS,S malaria vaccine in 27 health districts, aiming to immunize nearly 250,000 children aged 5 to 23 months. These districts, selected based on high case and death rates, will focus on strengthening immunity and reducing mortality.
The vaccine deployment provides hope for families in regions heavily affected by malaria. Healthcare professionals stress the importance of dispelling misinformation and fostering community trust to ensure widespread vaccine acceptance.
In the fight against malaria, the introduction of the RTS,S vaccine marks a significant advancement, offering relief to children and parents who have long battled the impact of this disease.
